Maya Ronse1, Julia Irani1, Charlotte Gryseels1, Tom Smekens1, Serge Ekukole2, Caroline Teh Monteh2, Peter Tatah Ntaimah3, Susan Dierickx4, Kristien Verdonck1, Robert Colebunders5, Alfred K Njamnshi2,6,7, Sarah O'Neill1,8,9, Koen Peeters Grietens1. 1. Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium. 2. Department of Internal Medicine (Neurology Unit), Faculty of Medicine and Biomedical Science, University of Yaoundé I, Yaoundé, Cameroon. 3. Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Buea, Cameroon. 4. Centre of Expertise on Gender, Diversity and Intersectionality (RHEA), Vrije Universiteit Brussel, Brussels, Belgium. 5. Global Health Institute, University of Antwerp, Antwerp, Belgium. 6. Department of Neurology, Central Hospital Yaoundé, Yaoundé, Cameroon. 7. Brain Research Africa Initiative (BRAIN), Yaoundé, Cameroon & Geneva, Switzerland. 8. Social Approaches to Health (CR5), Ecole de Santé Publique, Université Libre de Bruxelles, Brussels, Belgium. 9. Laboratoire Anthropologique des Mondes Contemporains (LAMC), Faculté de Philosophie et de Sciences Sociales, Université Libre de Bruxelles, Brussels, Belgium.
Abstract
BACKGROUND: A high prevalence of epilepsy has been observed in several onchocerciasis-endemic villages in the Sanaga River basin, Cameroon. Recent studies suggest that ivermectin, a drug that is distributed annually with the aim of eliminating onchocerciasis, may have a protective effect against acquiring onchocerciasis-associated epilepsy (OAE). This study, therefore, provides an in-depth understanding of both the complex therapeutic landscape for epilepsy as well as the experiences related to the 'community-directed treatment with ivermectin' (CDTI) campaign in order to identify a more trenchant path forward in the fight against epilepsy. METHODOLOGY/PRINCIPAL FINDINGS: Based on a mixed methods study combining a qualitative strand with a quantitative survey, we found that epilepsy was perceived to have had an epidemic emergence in the past and was still considered an important health issue in the study area. Socio-economic status, availability and accessibility of drugs and practitioners, as well as perceived aetiology shaped therapeutic itineraries for epilepsy, which included frequenting (in)formal biomedical health care providers, indigenous and/or faith healing practitioners. Ivermectin uptake for onchocerciasis was generally well known and well regarded. The CDTI faced structural and logistical bottlenecks undermining equal access and optimal adherence to the drug. CONCLUSIONS/SIGNIFICANCE: Locally accessible, uninterrupted, sustainable and comprehensive health-service delivery is essential to help alleviate the epilepsy burden on afflicted households. Addressing structural challenges of CDTI and communicating the potential link with epilepsy to local populations at risk could optimize the uptake of this potentially significant tool in OAE prevention.
BACKGROUND: A high prevalence of epilepsy has been observed in several onchocerciasis-endemic villages in the Sanaga River basin, Cameroon. Recent studies suggest that ivermectin, a drug that is distributed annually with the aim of eliminating onchocerciasis, may have a protective effect against acquiring onchocerciasis-associated epilepsy (OAE). This study, therefore, provides an in-depth understanding of both the complex therapeutic landscape for epilepsy as well as the experiences related to the 'community-directed treatment with ivermectin' (CDTI) campaign in order to identify a more trenchant path forward in the fight against epilepsy. METHODOLOGY/PRINCIPAL FINDINGS: Based on a mixed methods study combining a qualitative strand with a quantitative survey, we found that epilepsy was perceived to have had an epidemic emergence in the past and was still considered an important health issue in the study area. Socio-economic status, availability and accessibility of drugs and practitioners, as well as perceived aetiology shaped therapeutic itineraries for epilepsy, which included frequenting (in)formal biomedical health care providers, indigenous and/or faith healing practitioners. Ivermectin uptake for onchocerciasis was generally well known and well regarded. The CDTI faced structural and logistical bottlenecks undermining equal access and optimal adherence to the drug. CONCLUSIONS/SIGNIFICANCE: Locally accessible, uninterrupted, sustainable and comprehensive health-service delivery is essential to help alleviate the epilepsy burden on afflicted households. Addressing structural challenges of CDTI and communicating the potential link with epilepsy to local populations at risk could optimize the uptake of this potentially significant tool in OAE prevention.
Authors: Joseph F N Siewe; Leonard Ngarka; Godwin Tatah; Michel K Mengnjo; Leonard N Nfor; Eric S Chokote; Charlotte Boullé; Cyrille Nkouonlack; Fidèle Dema; Grace A Nkoro; Wepnyu Y Njamnshi; Earnest N Tabah; Anne-Cécile Zoung-Kanyi Bissek; Robert Colebunders; Alfred K Njamnshi Journal: Epilepsy Behav Date: 2018-12-01 Impact factor: 2.937
Authors: Cédric B Chesnais; Hugues C Nana-Djeunga; Alfred K Njamnshi; Cédric G Lenou-Nanga; Charlotte Boullé; Anne-Cécile Zoung-Kanyi Bissek; Joseph Kamgno; Robert Colebunders; Michel Boussinesq Journal: Lancet Infect Dis Date: 2018-09-26 Impact factor: 25.071
Authors: Koen Peeters Grietens; Elizabeth Toomer; Alphonse Um Boock; Susanna Hausmann-Muela; Hans Peeters; Kirezi Kanobana; Charlotte Gryseels; Joan Muela Ribera Journal: PLoS One Date: 2012-05-18 Impact factor: 3.240
Authors: Deby Mukendi; Floribert Tepage; Innocent Akonda; Joseph Nelson Fodjo Siewe; Anke Rotsaert; Carl Nwana Ndibmun; Anne Laudisoit; Simon Couvreur; Blandine Kabutako; Sonia Menon; An Hotterbeekx; Robert Colebunders Journal: Int J Infect Dis Date: 2019-02 Impact factor: 3.623
Authors: Robert Colebunders; Joseph Nelson Siewe Fodjo; Adrian Hopkins; An Hotterbeekx; Thomson L Lakwo; Akili Kalinga; Makoy Yibi Logora; Maria-Gloria Basáñez Journal: PLoS Negl Trop Dis Date: 2019-07-18
Authors: Sébastien D S Pion; Christoph Kaiser; Fernand Boutros-Toni; Amandine Cournil; Melanie M Taylor; Stefanie E O Meredith; Ansgar Stufe; Ione Bertocchi; Walter Kipp; Pierre-Marie Preux; Michel Boussinesq Journal: PLoS Negl Trop Dis Date: 2009-06-16